CAZZANIGA, MARINA ELENA

CAZZANIGA, MARINA ELENA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 115 (tempo di esecuzione: 0.022 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 01 - Articolo su rivista 1993 Cazzaniga, MPiperno, A +
Adjuvant systemic treatment of early breast cancer: the NORA study 01 - Articolo su rivista 2006 Cazzaniga M +
Bisphosphonates and metastatic bone disease 01 - Articolo su rivista 2006 Cazzaniga M +
The extension of disease is associated to an increased risk of venous thromboembolism (VTE) in patients with gastrointestinal (GI) carcinoma 01 - Articolo su rivista 2006 Cazzaniga M +
Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study 01 - Articolo su rivista 2007 Cazzaniga M +
Breast cancer in elderly women: a different reality? Results from the NORA study 01 - Articolo su rivista 2007 Cazzaniga M +
5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study 01 - Articolo su rivista 2007 Cazzaniga M +
From the trastuzumab era to new target therapies: beyond revolution 01 - Articolo su rivista 2007 Cazzaniga M +
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study 01 - Articolo su rivista 2007 Cazzaniga M +
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) [Trattamento con Gefitinib nei pazienti anziani o con scarso performance status (PS), affetti da carcinoma polmonare non a piccole cellule (NSCLC)] 01 - Articolo su rivista 2008 Ardizzoia ACazzaniga MGardani GBidoli P +
Treatment with gefitinib in elderly patients or patients with poor performance status (PS) affected with non small cell lung carcinoma (NSCLC) 01 - Articolo su rivista 2008 Arnoffi, JColombo, IVilla, FDapretto, ECazzaniga, MGardani, GBidoli, P +
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study 01 - Articolo su rivista 2008 Cazzaniga M +
Targeted therapies for the treatment of breast cancer in the post-trastuzumab era 01 - Articolo su rivista 2008 Cazzaniga M +
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study 01 - Articolo su rivista 2009 Cazzaniga M +
Isotretinoin plus clindamycin seem highly effective against severe erlotinib-induced skin rash in advanced non-small cell lung cancer 01 - Articolo su rivista 2010 Bidoli PCortinovis DLCazzaniga ME +
Biological characteristics and medical treatment of breast cancer in young women-a featured population: results from the NORA study 01 - Articolo su rivista 2011 Cazzaniga M +
Major issue in chemotherapy-induced peripheral neuropathy (cipn): lack of standardized measurement scales. ciperinoms study: validity and reliability in cipn assessment 02 - Intervento a convegno 2012 CORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENACAVALETTI, GUIDO ANGELOALBERTI, PAOLABidoli, P +
A Longitudinal Study on Oxaliplatin Induced Peripheral Neuropathy – Incidence and Facts About the “Real Life” Population And Actual Dose 02 - Intervento a convegno 2012 ALBERTI, PAOLACORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENABIDOLI, PAOLOCAVALETTI, GUIDO ANGELO
When progressive dysphagia could be related to an “old friend” – a case report 02 - Intervento a convegno 2012 ALBERTI, PAOLACORTINOVIS, DIEGO LUIGICAZZANIGA, MARINA ELENABIDOLI, PAOLOFERRARESE, CARLO +
Incidence, characteristics, and associations of oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: Results of a prospective, multicenter, international study. 02 - Intervento a convegno 2012 ALBERTI, PAOLACAZZANIGA, MARINA ELENACORTINOVIS, DIEGO LUIGICAVALETTI, GUIDO ANGELO +